Astec LifeSciences share news and announcements
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Last close ₹663.70down ₹5.50 (0.82%)BSE ₹664.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹669.20.
52-week range of traded prices to 23 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,479 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Apr 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- −4.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Apr 2026
- 1.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 33,48432.9% delivered
Astec LifeSciences board meetings
167 filed, newest first. Page 3 of 4.
Sep 2018
Aug 2018
1 Aug · Board meeting
1 Aug · Board meeting
Jul 2018
May 2018
2 May · Board meeting
Apr 2018
Jan 2018
31 Jan · Board meeting
17 Jan · Board meeting
Oct 2017
25 Oct · Board meeting
Jul 2017
May 2017
4 May · Board meeting
Apr 2017
Jan 2017
25 Jan · Board meeting
Oct 2016
Jul 2016
26 Jul · Board meeting
May 2016
5 May · Board meeting
Apr 2016
Jan 2016
29 Jan · Board meeting
Nov 2015
Oct 2015
13 Oct · Board meeting
Jul 2015
May 2015
Mar 2015
2 Mar · Board meeting
To transact the following business: 1. Re-appointment of Mr. Ashok V. Hiremath as Managing Director subject to the approval of members. 2. Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. 3. Any other business with the permission of Chair.
Feb 2015
Jan 2015
21 Jan · Board meeting
Inter alia, to consider following business: 1) to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014, after these results are reviewed by the Audit Committee, in terms of the provisions of clause 41 of the Listing Agreement and; 2) to consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/ - per share (including a premium of Rs. 98/- per share) on preferential basis to select persons/entities belonging to Non-Promoter Group, consequent to the approval of shareholders of the Company through Postal Ballot on January 20, 2015. Private placement offer letter is being sent to the select persons/entities belonging to Non-Promoter Group, as approved by Shareholders of the Company by passing of Special Resolution through Postal Ballot on January 20, 2015. 3) Any other matter with the permission of Chair.
Dec 2014
11 Dec · Board meeting
To consider and approve following items of agenda: 1) To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, to select persons/entities on such terms and conditions and at such price not lower than the price to be determined by SEBI (ICDR) Regulations, subject to the approval of members. 2) To approve the borrowing limits of the Company in compliance with the provisions of Section 180(1)(c) of the Companies Act, 2013. 3) To approve creation of charges on the assets of the Company in compliance with the provisions of Section 180(1)(a) of the Companies Act, 2013. 4) To grant Employee Stock Options to the employees of subsidiary companies of Astec LifeSciences Limited in compliance with terms and conditions of ESOP Scheme 2012, subject to the approval of members. 5) To authorize Director of the Company or Company Secretary to obtain the approval of members by way of conducting Postal ballot for item nos. 1, 2, 3 & 4 above. 6) Any other matter with the permission of Chair.
Oct 2014
8 Oct · Board meeting
To consider and approve amongst other items of agenda , the Unaudited Financial Results of the Company for the quarter ended September 30, 2014 after these results are reviewed by the Audit Committee. Further the Company's Code of Conduct for (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of unaudited financial results of the Company for the quarter ended September 30, 2014 for all the Officers and Designated Employees (including Directors) of the Company from October 09, 2014 till 24 hours after the announcement of the financial results of the Company to the Stock Exchanges (both days inclusive). Accordingly all Officers and Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window.
Aug 2014
11 Aug · Board meeting
Board of Directors at its meeting held on August 9, 2014, has: 1. Approved increase of Authorised Share Capital from Rs. 20,00,00,000/- ( Rupees Twenty Crores Only ) to Rs. 25,00,00,000/- ( Rupees Twenty five Crores Only ) by creation of Rs.5,00,00,000/- (Rupees Five Crores Only) dividend 50,00,000 ( Fifty Lakhs ) Equity Shares of Rs. 10/- ( Rupees Ten Only ) each. 2. Approved Alteration of Memorandum of Association to give effect to point which shall be subject to shareholders approval. 3. Adopted new set of Memorandum and articles of Association to bring it on compliance with Companies Act 2013 subject to shareholders approval.4 Aug · Board meeting
Inter-alia, to transact the following business: (1) To consider and approve the Unaudited financial accounts for the Quarter ended June 30, 2014, after these accounts are reviewed by Audit Committee.(2) To increase the Authorised Capital of the Company.(3) To alter Memorandum and Articles of Association of Company to give effect to item no.2 above.
Jun 2014
2 Jun · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, has accorded its consent to issuance of securities on preferential basis way of issue of Equity Shares/ Preference Shares/ Cumulative Convertible Bonds/ Debentures not exceeding Rupee 25 Crores (shall include premium thereon) at a price which shall be determined in accordance with the Guideline of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009.
May 2014
5 May · Board meeting
Inter alia, to transact the following business: (1) To consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended March 31, 2014, after these accounts are reviewed by Audit Committee. (2). To recommend dividend on Equity shares for the year ended March 31, 2014, if any.
Jan 2014
14 Jan · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2013 after these results are reviewed by the Audit Committee.
Oct 2013
14 Oct · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended September 30, 2013 after these results are reviewed by the Audit Committee.
Sep 2013
19 Sep · Board meeting
11 Sep · Board meeting
For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares.
Aug 2013
14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 12, 2013, considered the following : Due to resignation of M/s. P. M. Kathariya & Co., Chartered Accountants as the Statutory Auditor of the Company and as the Company is already in process of appointing M/s. Shah & Kathariya as new Auditor of the Company till the conclusion of next year's Annual General Meeting, the same is subject to shareholders to accord their approval for the appointment of new auditor. Therefore, Company will submit the Limited Review Report certified by the new Auditor for the quarter ended June 30, 2013 as soon as the Appointment of New Auditor will be in place.
Jul 2013
29 Jul · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended June 30, 2013 after these results are reviewed by the Audit Committee.
May 2013
27 May · Board meeting
Board of Directors of the Company at its meeting held on May 24, 2013 has approved the appointment of M/s. Shah & Kathariya, Chartered Accountants, Mumbai as Statutory Auditors of the Company for the Financial Year 2013-2014 in place of retiring Auditors M/s. P. M. Kathariya & Co., Chartered Accountants. The retiring Auditors expressed their inability to continue as Statutory Auditors of the Company due to their pre-occupations.14 May · Board meeting
Inter alia, to transact the following business : (1) To consider and approve the Standalone & Consolidated Audited Annual Accounts for the Quarter & Year Ended March 31, 2013, after these accounts are reviewed by Audit Committee; (2) To recommend dividend on the Equity shares for the year ended March 31, 2013, if any.
Feb 2013
7 Feb · Board meeting
To consider and approve amongst other items of agenda, the Unaudited Financial Results of the Company for the quarter ended December 31, 2012 after these results are reveiwed by the Audit Committee.
Jan 2013
4 Jan · Board meeting